Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2004-3-15
pubmed:abstractText
The decision about prophylactic oophorectomy is difficult for many premenopausal women with BRCA1/2 mutations because of concerns and controversy about the use of hormone replacement therapy (HRT) after oophorectomy.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1045-54
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:14981106-Adult, pubmed-meshheading:14981106-Age Factors, pubmed-meshheading:14981106-Cohort Studies, pubmed-meshheading:14981106-Decision Support Techniques, pubmed-meshheading:14981106-Estrogen Replacement Therapy, pubmed-meshheading:14981106-Female, pubmed-meshheading:14981106-Genes, BRCA1, pubmed-meshheading:14981106-Genes, BRCA2, pubmed-meshheading:14981106-Genetic Predisposition to Disease, pubmed-meshheading:14981106-Humans, pubmed-meshheading:14981106-Life Expectancy, pubmed-meshheading:14981106-Markov Chains, pubmed-meshheading:14981106-Middle Aged, pubmed-meshheading:14981106-Mutation, pubmed-meshheading:14981106-Ovarian Neoplasms, pubmed-meshheading:14981106-Ovariectomy, pubmed-meshheading:14981106-Postoperative Care, pubmed-meshheading:14981106-Risk, pubmed-meshheading:14981106-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis.
pubmed:affiliation
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6021, USA. karmstro@mail.med.upenn.edu
pubmed:publicationType
Journal Article